Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.

Will your teenaged patients be able to safely make their own decisions when they become adults? This clinical update helps you assess and advise your patients who aren’t ready to care for themselves about how to protect them from harm while trying to preserve their autonomy. 

Everyone has unconscious biases that impact how we care for our patients. This clinical update gives you tools to uncover and set aside implicit biases so that you can offer your patients with T21 or other conditions the opportunities they deserve to live their best lives. 

Managing polypharmacy in older adults can be tricky, especially when multiple clinicians are involved. We offer tips on how to find the right medication and dose while avoiding prescribing cascades. We also discuss how to use shared decision-making to deprescribe. 

Negative symptoms are the primary cause of disability in schizophrenia, and we identify a few antipsychotics and a few add-on therapies that can help. 

This neurohormone brings fast relief for postpartum depression, but whether it works in regular depression and how long its benefits last is another question.

Treating insomnia in older adults often comes with harms. Here we review how to get the diagnosis right, how to optimize treatment without medications, and how to find safer and more affordable medications when needed.